HG women in your area

To find women around the world willing to share their stories to help raise awareness of HG, please email annmarie@hyperemesis.org.

Speak with our HG Experts

To contact the HER Foundation for interviews, please email media@hyperemesis.org.

Media Relations Contacts

Please direct media inquiries to Ann Marie King at media@hyperemesis.org.

sick mother in bed
Woman getting Physical Therapy
Copy of F cus 1-min
HG baby
frustrated mom and baby

Our HG Experts

Dr. Marlena Fejzo, a Harvard-trained geneticist and researcher at University of Southern California, is the world's leading research scientist on HG and a HER Foundation Board member. Dr. Fejzo endured HG during her pregnancies.

Dr. Aimee Brecht-Doscher is an OBGYN in the Los Angeles area who has personally been affected by HG and is on the Board of the HER Foundation.

Kimber MacGibbon is a registered nurse (RN) and has helped many thousands of women since 2000 get through their HG pregnancies. She has an extensive understanding of HG from a medical and personal perspective. Kimber is also co-founder of the HER Foundation. She and Dr. Fejzo have co-authored over two dozen studies on HG in collaboration with universities, including USC and UCLA. Kimber had HG in both of her pregnancies. Email her at kimber @hyperemesis.org.

Jeremy King and Ann Marie King are co-founders of the HER Foundation and can offer a husband/wife perspective of what the HG couple is enduring together. Plus Mr. King provides a male perspective of the illness. He is quoted by saying years ago when wife was pregnant with child in 2002, "Calling HG morning sickness is like calling a hurricane a little bit of rain." You can email them directly at annmarie @hyperemesis.org or jeremy @hyperemesis.org


Marlena Fejzo, PhD, presents on HER’s genetic research at ASHG Annual Meeting 2021

By HER Foundation | October 22, 2021

Marlena Fejzo, PhD, HER Board Member and Research Advisor, presents at the American Society of Human Genetics Annual Meeting on the genetics of Hyperemesis Gravidarum (HG). Title of presentation: “Whole-exome sequencing confirms GDF15 is the greatest genetic risk factor for Hyperemesis Gravidarum and Identifies Rare and Novel Variants in appetite genes GDF15 and GFRAL” Conclusions…

Research Summary: Safety of Ondansetron (Zofran) in Pregnancy

By HER Foundation | October 17, 2021

2021 Dormuth CR, Winquist B, Fisher A, et al. Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort “This meta-analysis of cohort studies of 456,963 pregnancies in 3 countries published in JAMA, found treatment with ondansetron was not significantly associated with increased risk of fetal death,…

Celebrate 21 Years of Help and Hope for HG

By HER Foundation | October 16, 2021

The HER Foundation is 21! The Hyperemesis Education and Research Foundation’s mission is to provide Hyperemesis Gravidarum (HG) support, advocacy, education, and research to improve treatment  and outcomes. Here’s a listicle to celebrate 21 of the many ways HER has supported families! Launch the first website on HG to educate about treatment options, help those suffering from HG, and…